This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sikes, M. L.
Right arrow Articles by Oltz, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sikes, M. L.
Right arrow Articles by Oltz, E. M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, April 1999, p. 2773-2781, Vol. 19, No. 4
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Regulation of V(D)J Recombination by Transcriptional Promoters

Michael L. Sikes, Cristina C. Suarez, and Eugene M. Oltz*

Department of Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee 37232

Received 26 October 1998/Returned for modification 4 December 1998/Accepted 17 December 1998


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Enhancer elements potentiate the rearrangement of antigen receptor loci via changes in the accessibility of gene segment clusters to V(D)J recombinase. Here, we show that enhancer activity per se is insufficient to target T-cell receptor beta  miniloci for Dbeta Jbeta recombination. Instead, a promoter situated 5' to Dbeta 1 (PDbeta ) was required for efficient rearrangement of chromosomal substrates. A critical function for promoters in regulating gene segment accessibility was further supported by the ability of heterologous promoters to direct rearrangement of enhancer-containing substrates. Importantly, activation of a synthetic tetracycline-inducible promoter (Ptet) positioned upstream from the Dbeta gene segment was sufficient to target recombination of miniloci lacking a distal enhancer element. The latter result suggests that DNA loops, generated by interactions between flanking promoter and enhancer elements, are not required for efficient recognition of chromosomal gene segments by V(D)J recombinase. Unexpectedly, the Ptet substrate exhibited normal levels of rearrangement despite its retention of a hypermethylated DNA status within the Dbeta Jbeta cluster. Together, our findings support a model in which promoter activation, rather than intrinsic properties of enhancers, is the primary determinant for regulating recombinational accessibility within antigen receptor loci.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Precursor lymphocytes diversify immunoglobulin (Ig) and T-cell receptor (TCR) variable-region genes via a program of DNA recombination involving large arrays of variable (V), diversity (D), and joining (J) gene segments. All rearrangement events are mediated by a common V(D)J recombinase activity that targets conserved recognition sequences flanking each gene segment (32, 39). Despite these shared features, the rearrangement of antigen receptor loci proceeds in a tissue-, stage-, and allele-specific manner (39). For example, thymocytes specifically target TCR Dbeta and Jbeta gene segments for recombination upon commitment to the T-cell lineage. In turn, Dbeta Jbeta joins rearrange with one of 30 upstream Vbeta elements to complete assembly of a variable-region coding exon. The resultant expression of TCRbeta protein signals for a cessation of TCRbeta recombination and the initiation of TCRalpha gene assembly (42). Likewise, precursor B cells execute an ordered program of rearrangements at the Ig heavy-chain (IgH) and light-chain loci (8, 22). These observations indicate that precursor lymphocytes must direct and then redirect V(D)J recombinase activity to specific regions within antigen receptor loci at distinct stages of their development.

Recent studies have shown that the tissue- and stage-specific aspects of V(D)J rearrangement are governed by changes in the accessibility of gene segment clusters to recombinase proteins RAG-1 and RAG-2 (25, 41). An important role for enhancer elements in regulating the recombinational accessibility of linked gene segments has been deduced from numerous experimental approaches (reviewed in reference 39). For example, targeted deletion of Ig or TCR enhancers severely impairs recombination of gene segments specifically at the mutated alleles (1, 3, 6, 35, 40, 47). In addition, transgenic TCRbeta miniloci undergo rearrangement in precursor lymphocytes only upon inclusion of Ig or TCR enhancers (4, 11, 12, 29). In studies using a recombinase-inducible cell line, the latter results have been extended to show that any active enhancer, including those derived from a viral genome, directs efficient Dbeta Jbeta recombination within chromosomal miniloci (30). Despite these findings, the precise function of enhancer elements in regulating the rearrangement of associated gene segments remains unclear (39).

Prevailing models for enhancer-mediated control of V(D)J recombination invoke at least one of three effects exerted by these regulatory elements on neighboring gene segments. First, Ig and TCR enhancers activate transcription of germ line gene segments at developmental time points that coincide with their rearrangement (21, 31, 48). Second, the IgH enhancer (Eµ) has been shown to promote regional access to DNA-binding proteins, presumably via directed alterations in local chromatin configurations (17). Third, transcriptional enhancers protect chromosomal gene segments from active methylation and target hypermethylated sequences for demethylation (9, 19, 23). Each of these enhancer-dependent effects has been correlated with active recombination of linked gene segments (7, 24, 30, 34); however, their independent contributions to rearrangement efficiencies have not been established (39). Thus, it remains possible that enhancers directly regulate V(D)J recombination through their intrinsic abilities to potentiate the accessibility of neighboring chromatin. In this case, transcription and demethylation of gene segments would be simply by-products of enhancer function. Alternatively, enhancer-dependent activation of germ line promoters may be the critical parameter for directing efficient assembly of antigen receptor loci.

To dissect the role of transcriptional control elements in targeting V(D)J recombination, we have used a recombinase-inducible cell system to assess the rearrangement efficiency of chromosomal TCRbeta miniloci. Here, we show that enhancer activity is insufficient to target these substrates for Dbeta Jbeta recombination. Instead, a recently identified promoter situated 5' to the Dbeta 1 gene segment (PDbeta [37]) is absolutely required for enhancer-dependent rearrangement of chromosomal gene segments. Importantly, substitution of PDbeta with a synthetic promoter completely restores recombination of substrates lacking a distal enhancer element, despite their retention of a hypermethylated DNA status. Together, these findings suggest that activation of germ line promoter elements is the primary mechanism by which enhancers initiate assembly of variable-region gene segments.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Generation of stable TDR19 transfectants. The recombinase-inducible cell line TDR19 was generated by cotransfection of linearized pTET-R1, pTET-R2, pTET-tTAk (36), and pSV-HIS vectors (15) into the recombinase-null B-cell line M12. Transfected cells were selected in RPMI 1640 medium supplemented with 10% fetal calf serum, 2 mM L-glutamine, 0.01% penicillin-streptomycin, 50 µM beta -mercaptoethanol, tetracycline (0.5 µg/ml), and histidinol (3 mM). Southern blot analyses demonstrated that the TDR19 clone contained more than 10 copies each of the pTET-R1 and pTET-R2 vectors (38).

To prepare stable transfectants of TCRbeta recombination substrates, each minilocus (15 µg) was linearized with PvuI and electroporated (300 mV and 960 µF) together with linearized LTR-NEO expression vector (1.5 µg) into 107 TDR19 cells. Transfected cells were maintained in the presence of tetracycline and histidinol and were positively selected with G418 (1.5 mg/ml) after 48 h. The copy number and integrity of chromosomal miniloci in each clonal transfectant were determined by Southern blotting procedures as described previously (30). In most cases, analyses of germ line transcription and rearrangement were restricted to clones that harbored one to five copies of the test substrates.

Construction of TCRbeta recombination substrates. To dissect the components of recombinational accessibility, we generated a TCRbeta parental vector (D-/E-) that contained unique cloning sites at locations 5' (NotI) and 3' (XhoI) to the Jbeta 1 and Jbeta 2 gene segments. For this purpose, the 4.8-kb HindIII fragment spanning murine Vbeta 14 and the 600-bp BglII/BamHI fragment containing murine Jbeta 1 and Jbeta 2 segments were sequentially inserted into the HindIII and BamHI sites, respectively, of pGEM 11Z creating the D-/E-/Cµ- construct. The Sµ/Cµ region of the D-/E- construct was prepared from a 7.1-kb XbaI/EcoRI genomic fragment that was modified to destroy the internal XhoI site and linker ligated to replace the 5' XbaI site with a unique XhoI site. The modified Sµ/Cµ fragment was cloned into the corresponding XhoI/EcoRI sites in D-/E-/Cµ- polylinker sequences to yield the D-/E- vector. Finally, a blunt-ended 475-bp AluI/AluI fragment spanning iEkappa was cloned into the blunted XhoI site of D-/E- to produce the D-/E+ construct. To generate the phi /iEkappa minilocus, the AccI/BglII fragment spanning Dbeta 1 (430 bp), which lacks PDbeta , was ligated to NotI linkers and inserted into the unique NotI site present in D-/E+. Likewise, other promoter-Dbeta 1 combinations were inserted as either blunt-ended or NotI-linkered fragments into the unique NotI site located between the Vbeta 14 and Jbeta gene segments.

To prepare the promoter-Dbeta 1 combinations, each promoter element was positioned 5' of a 430-bp AccI/BglII fragment spanning Dbeta 1 that was subcloned into the SmaI site of pBluescript (Stratagene, La Jolla, Calif.). The individual promoters 5'Dbeta (2.3-kb HindIII/AccI fragment of the murine TCRbeta situated immediately 5' of Dbeta 1), PDbeta (377-bp KpnI/AccI fragment from the p377/3' vector [37]), PVkappa (325-bp HindIII fragment from the pIM.Kp.LUC vector [13]), PGK (phosphoglycerate kinase; 540-bp EcoRI/XhoI fragment from the PGKPuro vector [44]), and teto (tetracycline operon; 300-bp XhoI/KpnI fragment from the pTET-R2 vector [36]) were isolated. The iEkappa AluI/AluI fragment was generated by PCR amplification using the primers 5'Ekappa (5'-ATG CGG ATC CGC TTT TGT GTT TGA CC-3') and 3'Ekappa (5'-ATG CGA ATT CAA CCT ACT GTA TGG AC-3').

PCR analyses of coding and signal joins. For coding join analyses, genomic DNA was harvested from transfectants that were propagated in the presence or absence of tetracycline for 5 days. To minimize amplification of unrearranged TCRbeta miniloci, each DNA sample was digested with XbaI and ApaI, which both cleave at sites situated between the Dbeta 1 and Jbeta 1 gene segments. Extrachromosomal DNAs (30 µl) were prepared for signal join assays from 5 × 106 cells that were cultured in the presence or absence of tetracycline for 48 h (28).

Amplification of coding joins was performed in 50-µl reaction mixtures containing XbaI/ApaI-digested DNAs (500 ng for coding joins), 10 mM Tris-Cl (pH 8.3), 50 mM KCl, 2 mM MgCl2, 1 µg of bovine serum albumin per ml, 200 µM deoxynucleoside triphosphates, and 50 ng of each amplification primer (Table 1). Reaction mixtures were incubated at 72°C (3 min) prior to the addition of Taq polymerase (1.1 U) and amplified (94°C for 1 min, 60°C for 1 min, and 72°C for 1.5 min) for either 32 (Dbeta Jbeta coding), 27 (Vlambda Jlambda coding joins), or 25 (Clambda controls) cycles. The conditions for signal join amplifications were identical to those for Dbeta Jbeta coding joins but used 5 × 105 cell equivalents (3 µl) of extrachromosomal DNA. All PCR products were separated on 1.2 or 2% agarose gels and transferred to ZetaProbe membranes (Bio-Rad) for probe hybridization (Table 1).

Reverse transcription-PCR (RT-PCR) assay for germ line Dbeta Jbeta transcription. Total cellular mRNA was harvested by the LiCl method from clonal transfectants that were propagated for 72 h subsequent to tetracycline withdrawal. Reaction mixtures (20 µl) consisting of mRNA (3 µg), deoxynucleoside triphosphates (250 µM), random hexanucleotides (5 pmol), dithiothreitol (8.75 mM), and RNAsin (20 U; Promega) were preincubated at 65°C for 10 min to denature the RNAs and cooled rapidly to 42°C. Reverse transcription was initiated by immediate addition of MuLV reverse transcriptase (100 U; Perkin-Elmer) to each sample. The reaction mixtures were incubated at 42°C for 60 min, heat inactivated (75°C for 15 min), and stored at -20°C. To examine germ line expression, the resultant cDNAs (3 µl) were amplified with oligonucleotide primers specific for either Dbeta Jbeta Cµ (27 cycles) or beta -actin (25 cycles) transcripts, using the conditions described for Dbeta Jbeta coding join assays. Amplification products were separated on a 1% agarose gel, blotted to ZetaProbe membranes, and hybridized to the appropriate radiolabeled probes (Table 1).

Primers and probes. The sequences of oligonucleotide primers used for PCR amplification reactions and probes used for blot hybridizations are shown in Table 1.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Oligonucleotide primers used for PCR amplification reactions and probes used for blot hybridizations

DNA methylation analysis. The methylation status of chromosomal Ptet (see below) substrates was evaluated in transfectants maintained in the absence of tetracycline (in the presence of tTAk [see below]) for 5 days. Genomic DNAs (10 µg) were digested with appropriate combinations of restriction enzymes HindIII, HpaII, and MspI, separated on a 1% agarose gel, and transferred to ZetaProbe membranes. Southern blots were probed with a radiolabeled XbaI/BamHI fragment spanning the Jbeta 1 and Jbeta 2 gene segments as specified by the manufacturer (Bio-Rad).


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Enhancer-dependent regulation of Dbeta Jbeta rearrangement in recombinase-inducible cells. To expedite analyses of the molecular mechanisms that govern V(D)J recombination, we developed a B-cell system (TDR19) in which recombinase activity is expressed in an inducible manner. This strategy circumvents rearrangement of transfected substrates prior to their stable integration and allows us to specifically monitor the recombination potential of chromosomal gene segments. Prior studies have shown that coexpression of the recombination-activating genes RAG-1 and RAG-2 is sufficient to generate V(D)J recombinase activity in most mammalian cell lines (28, 32). Therefore, we prepared the TDR19 cell system by stable transfection of a recombinase-null B cell (M12) with RAG-1/2 expression vectors that were placed under the transcriptional control of a tetracycline-inducible promoter (Ptet [36]). In addition, the RAG cDNAs were cotransfected with an autoregulated expression vector encoding the chimeric Ptet-activating protein (tTAk [14, 36]), which binds to Ptet upon removal of tetracycline from the culture medium. The resultant TDR19 clone expressed undetectable levels of RAG transcripts in the presence of tetracycline. In contrast, 24 h after tetracycline withdrawal, levels of RAG gene expression in TDR19 were similar to those observed in primary thymocytes (38).

To validate their utility for studies of recombinational control, TDR19 cells were stably transfected with TCRbeta miniloci containing a single Vbeta 14 element linked to a portion of the Dbeta 1/Jbeta gene cluster (Fig. 1). Prior studies in transgenic mice have demonstrated that these miniloci faithfully recapitulate the enhancer dependence of TCRbeta gene assembly. Specifically, enhancer-containing miniloci were targeted for Dbeta Jbeta rearrangement in both B- and T-lineage cells, whereas enhancerless transgenes were recombinationally inert in developing lymphocytes (4, 12, 29). Based on these findings, we compared levels of substrate rearrangement in stable TDR19 transfectants harboring either an enhancerless TCRbeta minilocus (5'Dbeta /phi ) or a version containing the Ig kappa intronic enhancer (5'Dbeta /iEkappa ) (Fig. 1). Multiple independent clones for each substrate were cultured in the presence (without RAG) or absence (with RAG) of tetracycline for 5 days and analyzed for Dbeta Jbeta rearrangement in a semiquantitative PCR assay (Fig. 1, primers A and B). Subsequent to RAG gene induction, Dbeta Jbeta rearrangement was readily detected in all transfectants containing the iEkappa minilocus (Fig. 2, top panel, lanes 1 to 4). In contrast, enhancerless miniloci were refractory to recombinase activity, regardless of substrate integration site or copy number (Fig. 2, top panel, lanes 5 and 6; Table 2). Control PCR assays specific for Vlambda Jlambda rearrangement (2) at the constitutively accessible Iglambda locus confirmed that similar levels of recombinase activity were induced in each of the TDR19 transfectants (Fig. 2, middle panel). As such, TDR19 cells reproduce the enhancer-dependent regulation of Dbeta Jbeta rearrangement observed in animal models and provide a physiologically relevant system to test the effects of substrate alterations on recombinational accessibility.


View larger version (15K):
[in this window]
[in a new window]
 
FIG. 1.   Schematic depiction of modified TCRbeta miniloci. Unique restriction sites used for cloning promoter (NotI [N]) and enhancer (XhoI [X]) sequences are indicated. Arrows represent the relative positions of primers used for PCR amplification of Dbeta Jbeta coding joins (A and B) or Dbeta Jbeta Cµ cDNAs (C and D). Transcriptional regulatory elements: 5'Dbeta , 2.3-kb fragment of endogenous Dbeta 1 sequences; PDbeta , minimal 377-bp Dbeta 1 germ line promoter (37); PVkappa , the murine Vkappa 21C promoter (13); PGK, the rat PGK promoter (44); teto, a heptamer of the bacterial tetracycline operon (14); iEkappa , the murine Igkappa intronic enhancer (13).


View larger version (43K):
[in this window]
[in a new window]
 
FIG. 2.   Enhancer-dependent recombination of TCRbeta miniloci requires 5' Dbeta 1 sequences. Levels of Dbeta Jbeta rearrangements in chromosomal TCRbeta miniloci were analyzed by a semiquantitative PCR assay using primers A and B (Fig. 1). Letters above the lanes identify independent TDR19 clones harboring the substrates 5'Dbeta /iEkappa (lanes 1 to 4), 5'Dbeta /phi (lanes 5 and 6), and phi /iEkappa (lanes 7 to 11). Transfectants were incubated in the presence (without RAG) or absence (with RAG) of tetracycline for 5 days. The relative positions of amplification products corresponding to germ line miniloci (gl), as well as Dbeta Jbeta 1 (DJbeta 1) and Dbeta Jbeta 2 (DJbeta 2) rearrangements, are shown at the left. Control assays for recombinase activity (Vlambda Jlambda rearrangement) and total DNA content (Clambda ) in each sample are shown in the middle and bottom panels, respectively. The linearity of the Dbeta Jbeta coding join assay was confirmed by serial dilutions (lanes 12 to 17) of the 5'Dbeta /iEkappa sample shown in lane 2 with DNA harvested from the 5'Dbeta /phi sample shown in lane 6.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 2.   Summary of germ line expression and Dbeta -Jbeta rearrangement in TCRbeta minilocus transfectantsa

Distal enhancer activity is insufficient to target rearrangement of TCRbeta miniloci. In recent studies, we have shown that a promoter located directly 5' to the Dbeta 1 gene segment (PDbeta ) regulates germ line transcription of Dbeta 1/Jbeta gene segments in an enhancer-dependent manner (37). As an initial attempt to dissect the individual roles of promoter and enhancer elements in targeting recombination, we deleted 2 kb of 5' Dbeta 1 sequences from a TCRbeta minilocus that contained iEkappa . The resulting construct (phi /iEkappa [Fig. 1]), which lacks PDbeta , was stably transfected into TDR19 cells and assayed for Dbeta Jbeta rearrangement subsequent to induction of recombinase activity. Deletion of the 5'Dbeta 1 sequences severely impaired recombination of the TCRbeta minilocus in all clones examined (Fig. 2, lanes 7 to 11; Table 2). In addition to PDbeta , the deleted 5'Dbeta sequences span two regions that display DNase hypersensitivity in developing thymocytes (5). To test whether these regions were required for rearrangement of TCRbeta miniloci, we inserted the 377-bp minimal PDbeta element (37) at its native position in phi /iEkappa to generate the PDbeta /iEkappa substrate. Importantly, restoration of PDbeta was sufficient to support normal levels of Dbeta Jbeta joining following recombinase induction (Fig. 3A, lanes 5 to 8). Together, these data clearly demonstrate that enhancer activity per se is insufficient to direct recombination of linked gene segments. Instead, positive regulation of TCRbeta accessibility requires enhancer-dependent activation of the Dbeta 1 germ line promoter.


View larger version (62K):
[in this window]
[in a new window]
 
FIG. 3.   Promoter activation mediates Dbeta Jbeta rearrangement in chromosomal TCRbeta substrates. (A) Levels of Dbeta Jbeta rearrangements within TCRbeta /iEkappa substrates containing the minimal PDbeta (lanes 5 to 8), the Vkappa 21C (lanes 9 and 10), or the PGK (lanes 11 and 12) promoter element. Control PCRs with TDR19 transfectants containing the 5'Dbeta /iEkappa (lanes 1 and 2) or the promoterless (lanes 3 and 4) substrates are included for comparison. (B) Rearrangement levels in TDR19 transfectants harboring the Ptet/iEkappa (lanes 5 and 6), Ptet/phi (lanes 7 to 12), or iEkappa /PDbeta (lanes 13 to 18) minilocus. Other notation is as for Fig. 2.

The assembly of TCRbeta gene segments can be mediated by a diverse set of transcriptional enhancers, including those derived from viral genomes (1, 4, 30). Our finding that PDbeta also was required for Dbeta Jbeta rearrangement (Fig. 2) led us to test whether this promoter was unique in its ability to regulate recombination. For this purpose, we replaced PDbeta with either tissue-specific or generally active promoter elements and measured the recombination potential of each substrate in the TDR19 cell system. In enhancer-containing miniloci, a B-lymphocyte-specific promoter derived from the Vkappa 21C gene segment (PVkappa ) as well as a promoter that drives expression of the housekeeping gene encoding PGK directed normal levels of Dbeta Jbeta recombination (Fig. 3A, lanes 9 to 12). Thus, heterologous promoters can functionally replace PDbeta to support enhancer-dependent rearrangement of chromosomal miniloci.

Promoter activation targets Dbeta Jbeta rearrangement. The results presented in Fig. 2 and 3 favor a model in which promoter activation is the critical parameter for mediating efficient Dbeta Jbeta rearrangement. Alternatively, physical interactions between promoter- and enhancer-bound proteins might act to loop out intervening gene segments from the chromosome and thereby facilitate their recognition by recombinase. Indeed, prior studies have shown that promoter-enhancer interactions can significantly alter the structure of intervening chromatin (10). Further support for this loop model is provided by the regulatory architecture of all antigen receptor loci, in which germ line gene segments are flanked by 5' promoter and 3' enhancer elements.

To test the loop model of recombinational accessibility, we repositioned iEkappa in the TCRbeta substrate to a location upstream from the PDbeta element (Fig. 1). This configuration eliminates the potential for loops spanning the Dbeta Jbeta cluster but should retain transcriptional activation of the target gene segments. As shown in Fig. 3B, the iEkappa /PDbeta substrate was efficiently rearranged in TDR19 upon RAG gene induction (lanes 13 to 18). As an independent test of the requirement for DNA loops, we generated a TCRbeta minilocus that contained both the teto and iEkappa regulatory elements (Ptet/iEkappa [Fig. 1]). Because teto is activated solely by binding to the exogenous factor tTAk (14), the enhancer and promoter within Ptet/iEkappa should function independently. Consistent with results obtained for the iEkappa /PDbeta substrate, induction of tTAk expression in Ptet/iEkappa transfectants produced normal levels of Dbeta Jbeta joins (Fig. 3B, lanes 5 and 6).

Our results with the iEkappa /PDbeta and Ptet/iEkappa substrates suggested that efficient V(D)J recombination does not require participating gene segments to be flanked by enhancer-promoter pairs. However, all iEkappa /PDbeta transfectants harbored multiple copies of the recombination substrate. As such, we could not exclude the potential for interactions between promoter and enhancer elements situated within separate copies of tandemly integrated miniloci. Moreover, it remained possible that the tTAk activator could interact with factors bound to iEkappa , resulting in DNA loops. To directly address the requirement for distal enhancers in minilocus recombination, we generated the Ptet/phi substrate, which lacks iEkappa (Fig. 1). Removal of the downstream enhancer from Ptet substrate had no significant effect on induced levels of Dbeta Jbeta rearrangement in either single- or multiple-copy transfectants (Fig. 3B, lanes 7 to 12; Table 2). From these data, we conclude that interactions between flanking promoter and enhancer elements are dispensible for targeting recombination of chromosomal miniloci.

Germ line Dbeta Jbeta transcription correlates precisely with substrate recombination potential. The activation of enhancer elements within antigen receptor loci has been linked temporally with the onset of germ line transcription and V(D)J recombination at participating gene segments (4, 33). To assess whether Dbeta Jbeta joining in modified TCRbeta miniloci correlated with their germ line transcription, we analyzed TDR19 transfectants in an RT-PCR assay that specifically detected hybrid Dbeta Jbeta Cµ transcripts derived from unrearranged substrates (Fig. 1, primers C and D). In multiple independent transfectants, removal of either iEkappa or 5'Dbeta sequences spanning the PDbeta element abolished not only substrate rearrangement but germ line Dbeta Jbeta transcription as well (Fig. 4, lanes 1 to 7). In contrast, Dbeta Jbeta Cµ transcripts were readily detected in recombinationally active substrates containing iEkappa linked to either the minimal PDbeta element or heterologous promoters (lanes 8 to 16). These findings are fully consistent with prior studies, which have shown that PDbeta is functional in B cells when linked to active enhancer elements (30, 37). Importantly, germ line transcription and rearrangement were restored in miniloci lacking a distal enhancer by positioning teto upstream from the consensus TATA element within the Dbeta 1 recognition sequence (lanes 17 to 20). These functional correlations held true even for rare clones in which promoter/iEkappa substrates lacked both Dbeta Jbeta rearrangement and germ line transcripts (Table 2). As shown previously, these transfectants likely harbor substrate integrations into regions of heterochromatin (18). Thus, the results presented in Fig. 4 provide a direct correlation between the transcriptional activity of Dbeta Jbeta gene segments and their rearrangement potential.


View larger version (23K):
[in this window]
[in a new window]
 
FIG. 4.   Germ line expression of TCRbeta miniloci correlates with Dbeta Jbeta recombination. Total cellular RNAs were harvested from individual transfectants maintained in the presence (without tTAk) or absence (with tTAk) of tetracycline (TET) for 3 days. The resultant RNAs were subjected to RT-PCR amplification with primers C and D (Fig. 1), and the reaction products were analyzed by Southern blotting using an oligonucleotide probe derived from Jbeta 1 coding sequences (top panel). The relative positions of amplification products corresponding to germ line transcripts that were processed at either Jbeta 1 (Dbeta Jbeta 1Cµ) or Jbeta 2 (Dbeta Jbeta 2Cµ) 3' splice sites are shown at the left. Total cDNA levels were controlled in each sample by using a PCR assay specific for beta -actin transcripts (bottom panel). The linearity of each assay was confirmed with serial dilutions of cDNA (lanes 21 to 26) derived from the 5'Dbeta /iEkappa transfectant shown in lane 1.

Transcription and rearrangement of TCRbeta miniloci are independent of methylation status. In addition to transcription and recombination, enhancers direct the active demethylation of linked antigen receptor gene segments (7, 23). Several groups have proposed that demethylation leads to alterations in regional chromatin structure that promote accessibility to nuclear proteins, including RNA polymerase and V(D)J recombinase (26, 27). However, the lack of tractable experimental model systems has hampered previous efforts to establish causal relationships between enhancer activity, demethylation, transcription, and recombination of gene segments.

Our analyses clearly demonstrated that Ptet provides access to RNA polymerase and V(D)J recombinase in the absence of a distal enhancer (Fig. 3B and 4). However, these findings did not address the possibility that Ptet possesses demethylating activities associated with antigen receptor enhancer elements (20). To explore this possibility, we subjected Ptet/phi and Ptet/iEkappa transfectants to Southern blot analyses using the methylation-sensitive restriction enzyme HpaII and a probe spanning the Jbeta gene segment cluster. These analyses were designed to measure the relative degree of substrate DNA methylation at a CpG site that is equidistant from the Dbeta 1 and Jbeta 1 gene segments (Fig. 5A). As shown in Fig. 5B, HpaII completely digested this CpG site in all Ptet/iEkappa transfectants, indicating a hypomethylated status (lanes 2, 4, and 5). The HpaII site was also hypomethylated in Ptet/iEkappa substrates prior to induction of tTAk expression (data not shown), a finding consistent with the dominant role of Ig enhancer elements in protecting linked sequences from DNA methylation (7). In sharp contrast, the vast majority of HpaII sites were hypermethylated in Ptet miniloci that lacked iEkappa (lanes 7, 9, and 10). As a control, the CpG sites were efficiently digested in both substrates with the methylation-insensitive isoschizomer MspI (lanes 3 and 8). Similar results were obtained with blotting strategies that probed the methylation status of sequences located 3' to the Jbeta gene segments (data not shown).


View larger version (28K):
[in this window]
[in a new window]
 
FIG. 5.   Ptet activation targets Dbeta Jbeta rearrangement independent of substrate demethylation. (A) Schematic depiction of the Dbeta Jbeta regions within the Ptet/iEkappa and Ptet/phi substrates. The relative positions of HpaII/MspI (H/M) restriction sites within the parental HindIII fragments are highlighted. The sizes of predicted restriction fragments are shown below each diagram. (B) Methylation status of independent transfectants harboring Ptet/iEkappa (lanes 1 to 5) or Ptet/phi (lanes 6 to 10) substrates. Genomic DNA from each clone was digested with HindIII alone (-; lanes 1 and 6) or in combination with either HpaII (H; lanes 2, 4, 5, 7, 9, and 10) or MspI (M; lanes 3 and 8). Digested DNAs were analyzed by Southern blotting procedures using a radiolabeled probe spanning the Jbeta 1/Jbeta 2 gene segments (Fig. 6A). The relative positions (arrows) and sizes (left) of restriction fragments resulting from digestion at the HindIII sites (H3) or from further digestion by HpaII and MspI (H3 + H/M) are indicated.

In mammalian cells, stable methylation patterns of CpG sequences are established subsequent to DNA replication (26). However, the failure of Ptet/phi substrates to undergo demethylation could not be attributed to insufficient rounds of DNA replication, since genomic DNAs were derived from transfectants that had completed at least four rounds of cell division following promoter activation. As such, the data presented in Fig. 5 indicate that Ptet lacks at least one function associated with enhancer activity---the ability to control demethylation of neighboring chromosomal sequences. Coupled with our previous results, we conclude that efficient Dbeta Jbeta recombination can be dissociated from the regional methylation status of chromosomal miniloci.

Germ line promoter activation is required for generation of Dbeta Jbeta signal joins. Emerging studies suggest that in addition to controlling the initial access of Dbeta Jbeta gene segments to recombinase, the TCRbeta enhancer (Ebeta ) may affect the efficiency of coding join formation (16). A potential mechanistic explanation for these findings invokes transcriptional regulatory elements in the recruitment of DNA repair complexes to chromosomal breaks generated by recombinase cleavage. In contrast to coding join formation, Dbeta Jbeta signal ends were resolved with similar efficiencies in mice harboring wild-type or Ebeta -/- loci (16). As such, we reasoned that the levels of signal joins generated from each TCRbeta substrate would provide a more direct readout for gene segment accessibility. Moreover, since the Dbeta Jbeta intervening sequences are identical in all modified TCRbeta miniloci, the kinetics of signal join formation should be similar regardless of their substrate origin.

To test whether transcriptional regulatory elements were required for the generation of Dbeta Jbeta signal joins, we isolated extrachromosomal DNA from a panel of TDR19 transfectants 48 h after tetracycline withdrawal. The DNA from each transfectant was analyzed by a semiquantitative PCR assay that specifically detects the circular deletion products containing either Dbeta Jbeta 1 or Dbeta Jbeta 2 signal joins (Fig. 6A, primers C and E). Using this assay, we found that removal of either iEkappa or PDbeta severely impaired the generation of signal joins from TCRbeta miniloci (Fig. 6B, lanes 2 to 6). Importantly, signal junctions were efficiently formed in TDR19 transfectants harboring either the Ptet/iEkappa or Ptet/phi substrate (lanes 8 to 15). As an independent control for recombinase activity, we observed similar levels of Vlambda Jlambda signal joins in all of the induced clones (Fig. 6B, bottom panel). The parallel between levels of coding and signal joins in modified substrates strongly suggests that transcriptional promoters mediate initial access of chromosomal miniloci to the recombinase complex.


View larger version (32K):
[in this window]
[in a new window]
 
FIG. 6.   Promoterless and enhancerless substrates do not generate Dbeta Jbeta signal joins. (A) Diagram of the PCR assay used for signal join detection. The locations of amplification primers (C and E) as well as the predicted sizes of PCR products from Dbeta Jbeta 1 and Dbeta Jbeta 2 rearrangements are indicated. The relative positions of flanking promoter and enhancer elements are shown in the top diagram. (B) Levels of signal joins in TDR19 transfectants harboring the indicated miniloci 48 h after tetracycline withdrawal. The relative positions of amplification products corresponding to Dbeta Jbeta 1 and Dbeta Jbeta 2 signal joins are shown at the left. Control assays for recombinase activity (Vlambda Jlambda signal joins) are presented in the bottom panel. The linearity of each assay was confirmed by serial dilutions (lanes 15 to 20) of the 5'Dbeta /iEkappa sample shown in lane 2.


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Promoter activation targets V(D)J recombination. The tissue, stage, and allele specificity of antigen receptor gene assembly is achieved through programmed alterations in the efficiency of V(D)J recombination at individual gene segment clusters (39). The results presented in this report provide novel insights into the critical role played by transcriptional control elements in targeting recombinase to chromosomal gene segments. Specifically, we show that positive regulation of Dbeta Jbeta rearrangement within TCRbeta miniloci can be dissociated from intrinsic properties of enhancer elements (Fig. 2). Instead, efficient recombination of these gene segments requires the presence of a germ line promoter located directly upstream from the Dbeta Jbeta cluster (Fig. 3A). In light of these findings, we propose that the observed inhibition of endogenous TCRbeta rearrangement by targeted deletion of Ebeta (1, 3) may indirectly result from the strict enhancer dependence of PDbeta activity (37). Indeed, deletion of sequences spanning PDbeta 1 specifically impairs Dbeta 1 rearrangement at the endogenous TCRbeta locus without altering levels of Dbeta 2Jbeta recombination (46). Similarly, removal of a regulatory region located 5' to the Jalpha cluster that includes a functional germ line promoter has been shown to preferentially impair rearrangement of proximal Jalpha gene segments (45). Taken together, these studies suggest that the primary function of Ig and TCR enhancers for targeting V(D)J recombination is to provide cell type and stage specificity to the activity of individual germ line promoters.

The dual requirement for PDbeta and enhancers suggested that direct interactions between these regulatory elements may be essential for targeting Dbeta Jbeta rearrangement, perhaps via the formation of DNA loops. This requirement may underlie the unique functional architecture of antigen receptor loci, in which germ line promoter and enhancer elements are segregated to positions flanking gene segment clusters. A requirement for DNA loops would also be consistent with previous observations that selectable marker genes positioned adjacent to enhancer elements exert an inhibitory effect on the rearrangement of antigen receptor loci (1, 6, 43). In these loci, the flanking transcriptional unit may perturb enhancer-promoter interactions, squelching both germ line transcription and loop formation.

To test the requirement for DNA loops in mediating Dbeta Jbeta rearrangement, we generated a panel of substrates that either repositioned or removed the enhancer element from its distal position. Unexpectedly, no differences were observed in the recombination potential of miniloci that contained promoter and enhancer elements at flanking positions (PDbeta /iEkappa ) versus those in which both elements were colocalized upstream from the Dbeta Jbeta cluster (iEkappa /PDbeta ). Although interactions between regulatory elements in neighboring substrates could not be formally discounted in multicopy iEkappa /PDbeta transfectants, promoter activation by the adjacent enhancer should be strongly favored relative to long-range (>23 kb) activation by iEkappa . In this regard, we have previously shown that the simian virus 40 enhancer directed PDbeta activity when positioned within the TCRbeta minilocus but failed to activate transcription or rearrangement of 5'Dbeta /phi substrates when present in cointegrated drug resistance vectors (30). Consistent with the activity of iEkappa /PDbeta miniloci, rearrangement of single-copy substrates lacking a distal enhancer was restored by placement of teto 5' to the Dbeta 1 gene segment (Fig. 3). Thus, formation of DNA loops between flanking promoter and enhancer elements is not an absolute requirement for targeting efficient rearrangement of chromosomal gene segments. However, these findings do not exclude a potential role for DNA looping in subsequent stages of TCRbeta gene assembly, which may require the juxtaposition of more distant Vbeta and Dbeta gene segments in order to facilitate their recombination.

We observed a strict requirement for promoter activation to generate Dbeta Jbeta coding and signal joins in TCRbeta miniloci (Fig. 6), indicating that accessibility is the primary factor regulating recombination in these substrates. These data are fully consistent with recent findings that alterations in gene segment accessibility underlie the stage- and tissue-specific control of Igkappa and TCRdelta rearrangements (25, 41). What are the molecular features of promoter activation that potentiate access of chromosomal substrates to the recombinase complex? In this study, we clearly show that heterologous promoters, including PVkappa , PGK, and Ptet, can replace PDbeta to direct germ line transcription and rearrangement of chromosomal miniloci (Fig. 3 and 4). Because each of these promoters is regulated by a distinct set of transcription factors (37), their similar effects on Dbeta Jbeta recombination cannot be readily explained by a recruitment of specific transactivating proteins that are essential for mediating accessibility. Thus, it is tempting to invoke transcriptional initiation or readthrough as critical components of the mechanisms that control substrate accessibility to V(D)J recombinase. This model is further supported by striking correlations that exist between the expression of sterile transcripts and the rearrangement of corresponding gene segments (Fig. 4 and references 21, 30, 34, and 48). Prior studies have demonstrated that factor binding to DNA motifs, including promoters, induces localized alterations in chromatin configuration (10). However, more general access to enzymatic complexes may require transcriptional readthrough in order to accentuate or propagate these chromatin alterations (10, 25). Thus, the presence of germ line promoters, rather than simple factor-binding sites, may be essential for conferring maximum recombinational accessibility to gene segments situated within complex antigen receptor loci. Although final confirmation of any regulatory model awaits the targeted modification of endogenous loci, TCRbeta minilocus substrates provide a tractable experimental system to define the precise mechanisms by which promoters govern the initial access of gene segments to V(D)J recombinase.

Uncoupling V(D)J recombination from substrate demethylation. Prior studies have established a correlation between the demethylation of antigen receptor loci and their recombination (7, 9, 19, 23). In turn, demethylation of gene segments, as well as their transcription and recombination, have been firmly linked to the activation of enhancer elements in cis. For example, Eµ and iEkappa protect TCRbeta transgenes from de novo methylation in murine lymphocytes (11) and promote demethylation of substrates in cell models (7, 23). Despite extensive correlations, it has been difficult to dissect the individual contributions of these distinct processes to recombinational accessibility. We now demonstrate that a synthetic promoter (Ptet) can efficiently direct germ line transcription and Dbeta Jbeta rearrangement but not regional demethylation of TCRbeta miniloci (Fig. 5B). These results indicate that Ptet lacks a hallmark feature associated with enhancers that drive Ig and TCR gene expression---the ability to direct demethylation of neighboring sequences in a chromosomal context. More importantly, these data indicate that hypomethylation of TCRbeta miniloci is not essential for conferring recombinational accessibility to its composite gene segments. In this regard, prior studies have shown that demethylated IgH gene segments may be refractory to recombinase activity in the absence of germ line transcription (6). Overall, these findings strongly suggest that demethylation is a functional consequence of enhancer activation within a given locus, rather than a prerequisite for antigen receptor gene assembly.

Regulatory studies in recombinase-inducible cell models. The physiological relevance of the TDR19-TCRbeta model system is supported by its ability to recapitulate enhancer- and promoter-dependent recombination of the endogenous TCRbeta locus (1, 3, 46). Although targeted deletion of endogenous regulatory elements can be used to judge their relative contributions to locus rearrangement, the TDR19-TCRbeta system provides several distinct advantages for dissecting the molecular determinants of recombinational accessibility. For example, the framework TCRbeta minilocus, which lacks PDbeta and iEkappa , is devoid of elements that direct either germ line transcription or rearrangement, but the substrate can be manipulated to include a broad panel of regulatory sequences. In contrast, endogenous loci harbor numerous promoter and enhancer elements that may partially overlap in their regulatory functions (1, 16, 35, 46). Furthermore, the TDR19 system permits transcriptional analysis of gene segments at the precise time point that rearrangement occurs (i.e., upon induction of recombinase activity). Analogous studies in murine models are complicated by fluctuations in promoter-enhancer activities that accompany the developmental progression of lymphocyte populations (29). Thus, our ability to directly compare transcription and rearrangement of substrates in TDR19 will be extremely valuable for future studies designed to dissect the molecular mechanisms by which promoter activation targets V(D)J recombination.


    ACKNOWLEDGMENTS

We thank Rey Gomez and Guo Ming Zhang for technical assistance and David Schatz (Yale University) for the pTET-R1 and pTET-R2 constructs. We also thank D. Ballard, W. Khan, J. Hawiger, L. Van Kaer, S. Sessoms, and H. Bendall for valuable comments.

This work was supported by NIH grants AI36944, AI01412 (E.M.O.), and GM19597 (M.L.S.). E.M.O. is a Joe C. Davis Scholar.


    FOOTNOTES

* Corresponding author. Mailing address: Department of Microbiology and Immunology, Vanderbilt University Medical School, 1161 21st Ave., S. A4203 MCN, Nashville, TN 37232. Phone: (615) 343-3011. Fax: (615) 343-3318. E-mail: oltzem{at}ctrvax.vanderbilt.edu.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Bories, J.-C., J. Demengeot, L. Davidson, and F. W. Alt. 1996. Gene-targeted deletion and replacement mutations of the T-cell receptor beta -chain enhancer: the role of enhancer elements in controlling V(D)J recombination accessibility. Proc. Natl. Acad. Sci. USA 93:7871-7876[Abstract/Free Full Text].
2. Boudinot, P., A. M. Drapier, P. A. Cazenave, and P. Sanchez. 1994. Conserved distribution of lambda subtypes from rearranged gene segments to immunoglobulin synthesis in the mouse B cell repertoire. Eur. J. Immunol. 24:2013-2017[Medline].
3. Bouvier, G., F. Watrin, M. Naspetti, C. Verthuy, P. Nazuet, and P. Ferrier. 1996. Deletion of the mouse T-cell receptor beta  gene enhancer blocks alpha beta T-cell development. Proc. Natl. Acad. Sci. USA 93:7877-7881[Abstract/Free Full Text].
4. Capone, M., F. Watrin, C. Fernex, B. Horvat, B. Krippl, L. Wu, R. Scollay, and P. Ferrier. 1993. TCRbeta and TCRalpha gene enhancers confer tissue- and stage-specificity on V(D)J recombination events. EMBO J. 12:4335-4346[Medline].
5. Chattopadhay, S., C. E. Whitehurst, F. Schwenk, and J. Chen. 1998. Biochemical and functional analyses of chromatin changes at the TCRbeta gene locus during CD4-CD8- to CD4+CD8+ thymocyte differentiation. J. Immunol. 160:1256-1267[Abstract/Free Full Text].
6. Chen, J., F. Young, A. Bottaro, V. Stewart, R. K. Smith, and F. W. Alt. 1993. Mutations of the intronic IgH enhancer and its flanking sequences differentially affect accessibility of the JH locus. EMBO J. 12:4635-4645[Medline].
7. Demengeot, J., E. M. Oltz, and F. W. Alt. 1995. Promotion of V(D)J recombinational accessibility by the intronic Ekappa element: role of the kappa B motif. Int. Immunol. 7:1995-2003[Abstract/Free Full Text].
8. Ehlich, A., S. Schaal, H. Gu, D. Kitamura, W. Muller, and K. Rajewsky. 1993. Immunoglobulin heavy and light chain genes rearrange independently at early stages of B cell development. Cell 72:695-704[Medline].
9. Engler, P., A. Weng, and U. Storb. 1993. Influence of CpG methylation and target spacing on V(D)J recombination in a transgenic substrate. Mol. Cell. Biol. 13:571-577[Abstract/Free Full Text].
10. Felsenfeld, G., J. Boyes, J. Chung, D. Clark, and V. Studitsky. 1996. Chromatin structure and gene expression. Proc. Natl. Acad. Sci. USA 93:9384-9388[Abstract/Free Full Text].
11. Fernex, C., M. Capone, and P. Ferrier. 1995. The V(D)J recombinational and transcriptional activities of the immunoglobulin heavy-chain intronic enhancer can be mediated through distinct protein-binding sites in a transgenic substrate. Mol. Cell. Biol. 15:3217-3226[Abstract].
12. Ferrier, P., B. Krippl, T. K. Blackwell, A. J. W. Furley, H. Suh, A. Winoto, W. D. Cook, L. Hood, F. Constantini, and F. W. Alt. 1990. Separate elements control DJ and VDJ rearrangements in a transgenic recombination substrate. EMBO J. 9:117-125[Medline].
13. Fulton, R., and B. Van Ness. 1993. Kappa immunoglobulin promoters and enhancers display developmentally controlled interactions. Nucleic Acids Res. 21:4941-4947[Abstract/Free Full Text].
14. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551[Abstract/Free Full Text].
15. Hartman, S. C., and R. C. Mulligan. 1988. Two dominant selectable markers for gene transfer studies in mammalian cells. Proc. Natl. Acad. Sci. USA 85:8047-8051[Abstract/Free Full Text].
16. Hempel, W. M., P. Stanhope-Baker, N. Mathieu, F. Huang, M. S. Schlissel, and P. Ferrier. 1998. Enhancer control of V(D)J recombination at the TCRbeta locus: differential effects on DNA cleavage and joining. Genes Dev. 12:2305-2317[Abstract/Free Full Text].
17. Jenuwein, T., W. C. Forrester, R.-G. Qiu, and R. Grosscheld. 1993. The immunoglobulin µ enhancer core establishes local factor access in nuclear chromatin independent of transcriptional stimulation. Genes Dev. 7:2016-2032[Abstract/Free Full Text].
18. Jenuwein, T., W. C. Forrester, L. A. Fernandez-Herrero, G. Laible, M. Dull, and R. Grosschedl. 1997. Extension of chromatin accessibility by nuclear matrix attachment regions. Nature 385:269-272[Medline].
19. Kelley, D. E., B. A. Pollock, M. L. Atchison, and R. P. Perry. 1988. The coupling between enhancer activity and hypomethylation of kappa immunoglobulin genes is developmentally regulated. Mol. Cell. Biol. 8:930-939[Abstract/Free Full Text].
20. Kirillov, A., B. Kistler, R. Mostoslavsky, H. Cedar, T. Wirth, and Y. Bergman. 1996. A role for nuclear NF-kappa B in B-cell-specific demethylation of the Igkappa locus. Nat. Genet. 13:435-441[Medline].
21. Lennon, G. G., and R. P. Perry. 1990. The temporal order of appearance of transcripts from unrearranged and rearranged Ig genes in murine fetal liver. J. Immunol. 144:1983-1987[Abstract].
22. Li, Y. S., K. Hayakawa, and R. R. Hardy. 1993. The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver. J. Exp. Med. 178:951-960[Abstract/Free Full Text].
23. Lichtenstein, M., G. Keini, H. Cedar, and Y. Bergman. 1994. B cell-specific demethylation: a novel role for the intronic kappa  chain enhancer sequence. Cell 76:913[Medline].
24. Mather, E. L., and R. P. Perry. 1983. Methylation status and DNaseI sensitivity of immunoglobulin genes: changes associated with rearrangement. Proc. Natl. Acad. Sci. USA 80:4689-4693[Abstract/Free Full Text].
25. McMurry, M. T., C. Hernandez-Munain, P. Lauzurica, and M. S. Krangel. 1997. Enhancer control of local accessibility to V(D)J recombinase. Mol. Cell. Biol. 17:4553-4561[Abstract].
26. Mostoslavsky, R., and Y. Bergman. 1997. DNA methylation: regulation of gene expression and role in the immune system. Biochim. Biophys. Acta 1333:F29-F50[Medline].
27. Mostoslavsky, R., N. Singh, A. Kirillov, R. Pelanda, H. Cedar, A. Chess, and Y. Bergman. 1998. kappa chain monoallelic demethylation and the establishment of allelic exclusion. Genes Dev. 12:1801-1811[Abstract/Free Full Text].
28. Oettinger, M. A., D. G. Schatz, C. Gorka, and D. Baltimore. 1990. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248:1517-1523[Abstract/Free Full Text].
29. Okada, A., M. Mendelsohn, and F. Alt. 1994. Differential activation of transcription versus recombination of transgenic T cell receptor beta  variable region gene segments in B and T lineage cells. J. Exp. Med. 180:261-272[Abstract/Free Full Text].
30. Oltz, E. M., F. W. Alt, W.-C. Lin, J. Chen, G. Taccioli, S. Desiderio, and G. Rathbun. 1993. A V(D)J recombinase-inducible B-cell line: role of transcriptional enhancer elements in directing V(D)J recombination. Mol. Cell. Biol. 13:6223-6230[Abstract/Free Full Text].
31. Royer, H. D., D. Ramarli, O. Acuto, T. J. Campen, and E. L. Reinherz. 1985. Genes encoding the T-cell receptor alpha  and beta  subunits are transcribed in an ordered manner during intrathymic ontogeny. Proc. Natl. Acad. Sci. USA 82:5510-5514[Abstract/Free Full Text].
32. Schatz, D. G., M. A. Oettinger, and M. A. Schlissel. 1992. V(D)J recombination: molecular biology and regulation. Annu. Rev. Immunol. 10:359-383[Medline].
33. Scherer, D., J. Brockman, H. Bendall, G. Zhang, D. Ballard, and E. Oltz. 1996. Corepression of RelA and c-Rel inhibits immunoglobulin kappa gene transcription and rearrangement in pre-B lymphocytes. Immunity 5:563-574[Medline].
34. Schlissel, M. S., and D. Baltimore. 1989. Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription. Cell 58:1001-1007[Medline].
35. Serwe, M., and F. Sablitzky. 1993. V(D)J recombination in B cells is impaired but not blocked by targeted deletion of the immunoglobulin heavy chain intron enhancer. EMBO J. 12:2321-2327[Medline].
36. Shockett, P., M. Difilippantonia, N. Hellman, and D. G. Schatz. 1992. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc. Natl. Acad. Sci. USA 92:6522-6526[Abstract/Free Full Text].
37. Sikes, M. L., R. J. Gomez, J. Song, and E. M. Oltz. 1998. A developmental stage-specific promoter directs germline transcription of Dbeta Jbeta gene segments in precursor T lymphocytes. J. Immunol. 161:1399-1405[Abstract/Free Full Text].
38. Sikes, M. L., and E. M. Oltz. An inducible cell model for studies of V(D)J recombinational control. J. Immunol. Methods, in press.
39. Sleckman, B. P., J. R. Gorman, and F. W. Alt. 1996. Accessibility control of antigen-receptor variable-region gene assembly: role of cis-acting elements. Annu. Rev. Immunol. 14:459-481[Medline].
40. Sleckman, B. P., C. G. Bardon, R. Ferrini, L. Davidson, and F. W. Alt. 1997. Function of the TCRalpha enhancer in alpha beta and gamma delta T cells. Immunity 7:505-515[Medline].
41. Stanhope-Baker, P., K. M. Hudson, A. L. Shaffer, A. Constantinescu, and M. S. Schlissel. 1996. Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro. Cell 85:887-897[Medline].
42. Strominger, J. L. 1989. Developmental biology of T cell receptors. Science 244:943-950[Abstract/Free Full Text].
43. Takeda, S., Y.-R. Zou, H. Bluethmann, D. Kitamura, U. Muller, and K. Rajewsky. 1993. Deletion of the immunoglobulin kappa  chain intron enhancer abolishes kappa  chain gene rearrangement in cis but not lambda  chain gene rearrangement in trans. EMBO J. 12:2329-2336[Medline].
44. Tucker, K. L., C. Beard, J. Dausman, L. Jackson-Grusby, P. W. Laird, H. Lei, E. Li, and R. Jaenisch. 1996. Germ-line passage is required for establishment of methylation and expression patterns of imprinted but not of nonimprinted genes. Genes Dev. 10:1008-1020[Abstract/Free Full Text].
45. Villey, I., D. Caillol, F. Selz, P. Ferrier, and J.-P. de Villartay. 1996. Defect in rearrangement of the most 5' TCR-J alpha following targeted deletion of T early alpha (TEA): implications for TCR alpha locus accessibility. Immunity 5:331-342[Medline].
46. Whitehurst, C., and J. Chen. Personal communication.
47. Xu, Y., L. Davidson, F. W. Alt, and D. Baltimore. 1996. Deletion of the Igkappa light chain intronic enhancer/matrix attachment region impairs but does not abolish Vkappa Jkappa rearrangement. Immunity 4:377-385[Medline].
48. Yancopoulos, G. D., and F. W. Alt. 1985. Developmentally controlled and tissue-specific expression of unrearranged VH gene segments. Cell 40:271-281[Medline].


Molecular and Cellular Biology, April 1999, p. 2773-2781, Vol. 19, No. 4
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Carpenter, A. C., Yang-Iott, K. S., Chao, L. H., Nuskey, B., Whitlow, S., Alt, F. W., Bassing, C. H. (2009). Assembled DJ{beta} Complexes Influence TCR{beta} Chain Selection and Peripheral V{beta} Repertoire. J. Immunol. 182: 5586-5595 [Abstract] [Full Text]  
  • Shani, N., Rubin-Lifshitz, H., Peretz-Cohen, Y., Shkolnik, K., Shinder, V., Cohen-Sfady, M., Shav-Tal, Y., Barda-Saad, M., Zipori, D. (2009). Incomplete T-cell receptor-{beta} peptides target the mitochondrion and induce apoptosis. Blood 113: 3530-3541 [Abstract] [Full Text]  
  • McMillan, R. E., Sikes, M. L. (2008). Differential Activation of Dual Promoters Alters D{beta}2 Germline Transcription during Thymocyte Development. J. Immunol. 180: 3218-3228 [Abstract] [Full Text]  
  • Ranganath, S., Carpenter, A. C., Gleason, M., Shaw, A. C., Bassing, C. H., Alt, F. W. (2008). Productive Coupling of Accessible V{beta}14 Segments and DJ{beta} Complexes Determines the Frequency of V{beta}14 Rearrangement. J. Immunol. 180: 2339-2346 [Abstract] [Full Text]  
  • Maes, J., Chappaz, S., Cavelier, P., O'Neill, L., Turner, B., Rougeon, F., Goodhardt, M. (2006). Activation of V(D)J Recombination at the IgH Chain JH Locus Occurs within a 6-Kilobase Chromatin Domain and Is Associated with Nucleosomal Remodeling. J. Immunol. 176: 5409-5417 [Abstract] [Full Text]  
  • Afshar, R., Pierce, S., Bolland, D. J., Corcoran, A., Oltz, E. M. (2006). Regulation of IgH Gene Assembly: Role of the Intronic Enhancer and 5'DQ52 Region in Targeting DHJH Recombination. J. Immunol. 176: 2439-2447 [Abstract] [Full Text]  
  • Perlot, T., Alt, F. W., Bassing, C. H., Suh, H., Pinaud, E. (2005). Elucidation of IgH intronic enhancer functions via germ-line deletion. Proc. Natl. Acad. Sci. USA 102: 14362-14367 [Abstract] [Full Text]  
  • Borghesi, L., Hsu, L.-Y., Miller, J. P., Anderson, M., Herzenberg, L., Herzenberg, L., Schlissel, M. S., Allman, D., Gerstein, R. M. (2004). B Lineage-specific Regulation of V(D)J Recombinase Activity Is Established in Common Lymphoid Progenitors. JEM 199: 491-502 [Abstract] [Full Text]  
  • Ryu, C. J., Haines, B. B., Draganov, D. D., Kang, Y. H., Whitehurst, C. E., Schmidt, T., Hong, H. J., Chen, J. (2003). The T cell receptor {beta} enhancer promotes access and pairing of D{beta} and J{beta} gene segments during V(D)J recombination. Proc. Natl. Acad. Sci. USA 100: 13465-13470 [Abstract] [Full Text]  
  • Yang, X. O., Doty, R. T., Hicks, J. S., Willerford, D. M. (2003). Regulation of T-cell receptor D{beta}1 promoter by KLF5 through reiterated GC-rich motifs. Blood 101: 4492-4499 [Abstract] [Full Text]  
  • Bassing, C. H., Tillman, R. E., Woodman, B. B., Canty, D., Monroe, R. J., Sleckman, B. P., Alt, F. W. (2003). T cell receptor (TCR) alpha /delta locus enhancer identity and position are critical for the assembly of TCR delta and alpha variable region genes. Proc. Natl. Acad. Sci. USA 100: 2598-2603 [Abstract] [Full Text]  
  • Sikes, M. L., Meade, A., Tripathi, R., Krangel, M. S., Oltz, E. M. (2002). Regulation of V(D)J recombination: A dominant role for promoter positioning in gene segment accessibility. Proc. Natl. Acad. Sci. USA 99: 12309-12314 [Abstract] [Full Text]  
  • Bender, C. F., Sikes, M. L., Sullivan, R., Huye, L. E., Le Beau, M. M., Roth, D. B., Mirzoeva, O. K., Oltz, E. M., Petrini, J. H. J. (2002). Cancer predisposition and hematopoietic failure in Rad50S/S mice. Genes Dev. 16: 2237-2251 [Abstract] [Full Text]  
  • Tripathi, R., Jackson, A., Krangel, M. S. (2002). A Change in the Structure of V{beta} Chromatin Associated with TCR {beta} Allelic Exclusion. J. Immunol. 168: 2316-2324 [Abstract] [Full Text]  
  • Bendall, H. H., Sikes, M. L., Oltz, E. M. (2001). Transcription Factor NF-{{kappa}}B Regulates Ig{{lambda}} Light Chain Gene Rearrangement. J. Immunol. 167: 264-269 [Abstract] [Full Text]  
  • Krangel, M. S. (2001). V(D)j Recombination Becomes Accessible. JEM 193: f27-f30 [Full Text]  
  • Mathieu, N., Hempel, W. M., Spicuglia, S., Verthuy, C., Ferrier, P. (2000). Chromatin Remodeling by the T Cell Receptor (Tcr)-{beta} Gene Enhancer during Early T Cell Development: Implications for the Control of Tcr-{beta} Locus Recombination. JEM 192: 625-636 [Abstract] [Full Text]  
  • HERNANDEZ-MUNAIN, C., MCMURRY, M. T., KRANGEL, M.S. (1999). Regulation of Chromatin Accessibility for V(D)J Recombination. Cold Spring Harb Symp Quant Biol 64: 183-190 [Abstract]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sikes, M. L.
Right arrow Articles by Oltz, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sikes, M. L.
Right arrow Articles by Oltz, E. M.